Work Here?
PCI Pharma Services
Work Here?
Pharmaceutical packaging and contract services
PCI Pharma Services
Work Here?
Pharmaceutical packaging and contract services
Overview
PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.
About PCI Pharma Services
Industries
Industrial & Manufacturing
Healthcare
Company Size
1-10
Company Stage
Debt Financing
Total Funding
$4B
Headquarters
Burlington, Canada
Founded
1971
Simplify's Take
What believers are saying
- San Diego’s 2028 line more than doubles RTU syringe and cartridge capacity.
- Bedford’s line reaches 33 million annual vial units, strengthening sterile supply.
- Autoinjector capacity exceeds 250 million units annually after the 2027 line.
What critics are saying
- San Diego capacity arrives only in first-half 2028, leaving competitors more immediate supply.
- Large sterile buildouts create execution risk from validation, yield, and regulatory delays.
- Customer concentration can strand expensive capacity if programs are delayed or cancelled.
What makes PCI Pharma Services unique
- PCI combines sterile fill-finish, device assembly, packaging, and cold-chain support.
- San Diego and Bedford add specialized capacity for prefilled syringes, vials, and lyophilization.
- Phased U.S. and European investments target clinical-through-commercial drug-device programs.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$4B
Above
Industry Average
Funded Over
0 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
401(k) Retirement Plan
Health Savings Account/Flexible Spending Account
Company News
On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.
PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.
Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.
PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.
PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.
PCI Pharma Services is Hiring for 165 Jobs on Simplify!
Find jobs on Simplify and start your career today
About PCI Pharma Services
Industries
Industrial & Manufacturing
Healthcare
Company Size
1-10
Company Stage
Debt Financing
Total Funding
$4B
Headquarters
Burlington, Canada
Founded
1971
PCI Pharma Services is Hiring for 165 Jobs on Simplify!
Find jobs on Simplify and start your career today